InMode (INMD) FCF Margin Growth (3y) (2021 - 2026)
InMode (INMD) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | -126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.00 |
| Dec 31, 2025 | -2,069.00 |
| Sep 30, 2025 | -1,152.00 |
| Jun 30, 2025 | -1,646.00 |
| Mar 31, 2025 | -1,928.00 |
| Dec 31, 2024 | -1,462.00 |
| Sep 30, 2024 | -2,766.00 |
| Jun 30, 2024 | -499.00 |
| Mar 31, 2024 | -787.00 |
| Dec 31, 2023 | -710.00 |
| Sep 30, 2023 | -1,695.00 |
| Jun 30, 2023 | 3,405.00 |
| Mar 31, 2023 | 485.00 |
| Dec 31, 2022 | -1,567.00 |
| Sep 30, 2022 | 401.00 |
| Jun 30, 2022 | -604.00 |
| Mar 31, 2022 | 2,711.00 |
| Dec 31, 2021 | 1,484.00 |
| Sep 30, 2021 | 2,511.00 |
| Jun 30, 2021 | 216.00 |